• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports.在线 ECHO 干预扩大阿片类药物使用障碍、心理社会治疗和支持的药物治疗的可行性和可接受性。
Subst Abus. 2021;42(4):610-617. doi: 10.1080/08897077.2020.1806184. Epub 2020 Aug 19.
2
Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.农村基层医疗中 MOUD ECHO 参与度对丁丙诺啡处方扩展的影响。
Subst Abus. 2023 Oct;44(4):282-291. doi: 10.1177/08897077231198971. Epub 2023 Oct 30.
3
Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.利益相关者对远程医疗转诊和协调模式的看法,以扩大农村初级保健诊所中美沙酮药物治疗物质使用障碍的治疗。
J Subst Use Addict Treat. 2024 Jan;156:209194. doi: 10.1016/j.josat.2023.209194. Epub 2023 Oct 18.
4
Augmenting project ECHO for opioid use disorder with data-informed quality improvement.利用数据驱动的质量改进来增强 ECHO 项目治疗阿片类药物使用障碍。
Addict Sci Clin Pract. 2023 Apr 28;18(1):24. doi: 10.1186/s13722-023-00381-2.
5
Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.北卡罗来纳州基于诊所用丁丙诺啡治疗阿片类药物使用障碍的 ECHO 干预措施的障碍和感知有用性:一项定性研究。
Subst Abus. 2021;42(1):54-64. doi: 10.1080/08897077.2019.1694617. Epub 2019 Dec 6.
6
Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program.在公共资助的基层医疗诊所中扩大阿片类药物使用障碍的治疗:对纽约市卫生+医院丁丙诺啡 ECHO 项目的探索性评估。
J Subst Abuse Treat. 2019 Nov;106:1-3. doi: 10.1016/j.jsat.2019.08.003. Epub 2019 Aug 9.
7
Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.招募农村初级保健提供者以实施专注于阿片类药物使用障碍药物治疗(MOUD)的综合护理模式的策略。
Implement Res Pract. 2023 Feb 19;4:26334895231152808. doi: 10.1177/26334895231152808. eCollection 2023 Jan-Dec.
8
Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities.临床领导人和提供者对在退伍军人事务部设施中提供治疗阿片类药物使用障碍的药物的看法。
Addict Sci Clin Pract. 2021 Sep 6;16(1):55. doi: 10.1186/s13722-021-00263-5.
9
The who, the what, and the how: A description of strategies and lessons learned to expand access to medications for opioid use disorder in rural America.谁、什么以及如何:美国农村地区扩大阿片类药物使用障碍药物可及性的策略及经验教训描述
Subst Abus. 2021;42(2):123-129. doi: 10.1080/08897077.2021.1891492. Epub 2021 Mar 9.
10
Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.阶梯式阿片类药物使用障碍治疗培训师计划(SCOUTT):在退伍军人健康管理局设施内扩大阿片类药物使用障碍药物治疗的获取途径。
Subst Abus. 2020;41(3):275-282. doi: 10.1080/08897077.2020.1787299.

引用本文的文献

1
Innovations to the ECHO model to enhance reach and network-building among addiction clinicians in Western Canada.对扩展社区医疗成果(ECHO)模式的创新,以提高加拿大西部成瘾临床医生的覆盖面并加强网络建设。
Addict Sci Clin Pract. 2024 Dec 18;19(1):93. doi: 10.1186/s13722-024-00524-z.
2
Feasibility, acceptability, and perceived usefulness of a community-evidence-based harm reduction intervention for sexualized stimulant use among Mexican gay, bisexual, and other men who have sex with men.一种基于社区证据的性化兴奋剂使用减少伤害干预措施在墨西哥男同性恋、双性恋和其他与男性发生性关系的男性中的可行性、可接受性和感知有用性。
Harm Reduct J. 2024 May 16;21(1):95. doi: 10.1186/s12954-024-01020-y.
3
Evaluation and guide for embedding opioid use disorder education in health professions' curricula.评估并指导将阿片类药物使用障碍教育纳入卫生专业课程。
BMC Med Educ. 2023 Mar 1;23(1):135. doi: 10.1186/s12909-023-04088-5.
4
Use of a Community Engagement and Research Core model to enhance primary care provider recruitment: A case example.使用社区参与和研究核心模型来加强初级保健提供者的招募:一个案例
J Clin Transl Sci. 2022 Nov 25;7(1):e11. doi: 10.1017/cts.2022.505. eCollection 2023.
5
Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care.探讨在农村基层医疗中未采用 MOUD 的人群提供培训激励的问题。
Addict Sci Clin Pract. 2022 Dec 14;17(1):72. doi: 10.1186/s13722-022-00353-y.
6
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites.通过与城市站点进行定性比较,确定在农村急诊科实施基于同伴的阿片类药物使用障碍服务的独特障碍。
Addict Sci Clin Pract. 2022 Jul 28;17(1):41. doi: 10.1186/s13722-022-00324-3.
7
Experiences and perceptions of nurses participating in an interprofessional, videoconference-based educational programme on concurrent mental health and substance use disorders: a qualitative study.护士参与基于视频会议的跨专业心理健康与物质使用障碍并发教育项目的经历与看法:一项定性研究
BMC Nurs. 2022 Jul 4;21(1):177. doi: 10.1186/s12912-022-00943-w.
8
Feasibility, acceptability, and sustainability of Project ECHO to expand capacity for pediatricians in Vietnam.在越南,利用 ECHO 项目扩大儿科医生的能力:可行性、可接受性和可持续性。
BMC Health Serv Res. 2021 Dec 9;21(1):1317. doi: 10.1186/s12913-021-07311-5.
9
A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.一项针对 Veterans Health Administration 中涉及法律问题的退伍军人中阿片类药物使用障碍药物治疗的障碍和促进因素的全国性调查。
Subst Abus. 2022;43(1):556-563. doi: 10.1080/08897077.2021.1975867. Epub 2021 Sep 29.
10
New and Emerging Opioid Overdose Risk Factors.新型及新兴阿片类药物过量风险因素
Curr Addict Rep. 2021;8(2):319-329. doi: 10.1007/s40429-021-00368-6. Epub 2021 Apr 22.

本文引用的文献

1
Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program.在公共资助的基层医疗诊所中扩大阿片类药物使用障碍的治疗:对纽约市卫生+医院丁丙诺啡 ECHO 项目的探索性评估。
J Subst Abuse Treat. 2019 Nov;106:1-3. doi: 10.1016/j.jsat.2019.08.003. Epub 2019 Aug 9.
2
U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018.2016 年和 2018 年美国具有开具丁丙诺啡用于治疗阿片类药物使用障碍处方豁免资质的提供者供应趋势。
Drug Alcohol Depend. 2019 Nov 1;204:107527. doi: 10.1016/j.drugalcdep.2019.06.029. Epub 2019 Aug 30.
3
Engagement With Project ECHO to Increase Medication-Assisted Treatment in Rural Primary Care.参与 ECHO 项目以增加农村基层医疗中的药物辅助治疗。
Psychiatr Serv. 2019 Dec 1;70(12):1157-1160. doi: 10.1176/appi.ps.201900142. Epub 2019 Aug 22.
4
Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.宾夕法尼亚州农村获取 MAT(RAMP):一项混合实施研究方案,旨在促进农村初级保健提供者采用药物辅助治疗。
Addict Sci Clin Pract. 2019 Aug 1;14(1):25. doi: 10.1186/s13722-019-0154-4.
5
Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.药物和阿片类药物滥用相关的过量死亡-美国,2013-2017 年。
MMWR Morb Mortal Wkly Rep. 2018 Jan 4;67(5152):1419-1427. doi: 10.15585/mmwr.mm675152e1.
6
Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington.在华盛顿州斯波坎县,距离增加与阿片类药物治疗计划的每日出勤率降低有关。
J Subst Abuse Treat. 2018 Oct;93:26-30. doi: 10.1016/j.jsat.2018.07.006. Epub 2018 Jul 24.
7
Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.农村医生开具丁丙诺啡处方的规定豁免。
Am J Prev Med. 2018 Jun;54(6 Suppl 3):S208-S214. doi: 10.1016/j.amepre.2018.02.006.
8
Making the Opioid Public Health Emergency Effective.让阿片类药物公共卫生紧急事件发挥作用。
JAMA Psychiatry. 2018 Aug 1;75(8):767-768. doi: 10.1001/jamapsychiatry.2018.0611.
9
ECHO Pain Curriculum: Balancing Mandated Continuing Education With the Needs of Rural Health Care Practitioners.ECHO疼痛课程:平衡强制继续教育与农村医疗从业者的需求
J Contin Educ Health Prof. 2017 Summer;37(3):190-194. doi: 10.1097/CEH.0000000000000165.
10
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.农村医生在开具丁丙诺啡治疗阿片类药物使用障碍方面面临的障碍。
Ann Fam Med. 2017 Jul;15(4):359-362. doi: 10.1370/afm.2099.

在线 ECHO 干预扩大阿片类药物使用障碍、心理社会治疗和支持的药物治疗的可行性和可接受性。

Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports.

机构信息

Department of Psychiatry and Behavioral Sciences, Health Sciences Center, University of New Mexico, Albuquerque, New Mexico, USA.

Addictions and Substance Abuse Program, University of New Mexico Hospital, Albuquerque, New Mexico, USA.

出版信息

Subst Abus. 2021;42(4):610-617. doi: 10.1080/08897077.2020.1806184. Epub 2020 Aug 19.

DOI:10.1080/08897077.2020.1806184
PMID:32814005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8552422/
Abstract

Buprenorphine combined with psychosocial support is the standard of care for treatment of opioid use disorder (OUD) in office-based primary care settings. However, uptake of this treatment has been slow due to a number of addressable barriers including providers' lack of training, staffing concerns, stigma and the need for ongoing support and consultation. This study examined acceptability and feasibility of an online Extensions for Community Healthcare Outcomes (ECHO) model intervention developed to support rural primary care clinics to expand treatment and is part of a larger study tracking the impact of participation in this ECHO on expansion of MOUD in rural primary care. We developed a comprehensive, 12-week online education and mentorship intervention using ECHO aimed at supporting the entire primary care clinic to start or expand treatment using MOUD, psychosocial treatments and recovery supports. We tracked participation and collected feedback using qualitative interviews and post-session questionnaires. Sixty-seven primary care staff across 27 rural clinics in New Mexico participated in the study including 32 prescribers and 35 clinic support staff. Average participation was 4/12 sessions. Post-session questionnaires showed positive feedback, including that 95% or more respondents agreed or strongly agreed that the sessions were relevant and improved their confidence. Qualitative interview themes included strong endorsement of the ECHO curriculum. Clinical duties were the most common barrier to attending sessions. Engagement of 27 clinics, the range of staff and providers who participated, and positive feedback gathered through survey and qualitative interviews provide evidence of feasibility and acceptability of MOUD ECHO to support expansion of this treatment. However, barriers to participation present an important threat to feasibility. Understanding feasibility and acceptability is an important component of research on the impact of ECHO to expand MOUD treatment.

摘要

丁丙诺啡联合心理社会支持是治疗门诊初级保健环境中阿片类药物使用障碍(OUD)的标准治疗方法。然而,由于一些可解决的障碍,包括提供者缺乏培训、人员配备问题、污名化以及对持续支持和咨询的需求,这种治疗方法的采用一直很缓慢。这项研究考察了一种在线扩展社区医疗保健结果(ECHO)模型干预措施的可接受性和可行性,该干预措施旨在支持农村初级保健诊所扩大治疗范围,这是一项更大规模研究的一部分,该研究跟踪了参与该 ECHO 对农村初级保健中扩大 OUD 治疗的影响。 我们开发了一种综合的、为期 12 周的在线教育和指导干预措施,使用 ECHO 旨在支持整个初级保健诊所开始或扩大使用 OUD、心理社会治疗和康复支持的治疗。我们通过定性访谈和课后问卷调查来跟踪参与情况并收集反馈。 来自新墨西哥州 27 个农村诊所的 67 名初级保健工作人员参与了这项研究,包括 32 名处方医生和 35 名诊所支持人员。平均参与率为 12 节课中的 4 节。课后问卷调查显示出积极的反馈,包括 95%或更多的受访者同意或强烈同意课程相关且提高了他们的信心。定性访谈主题包括对 ECHO 课程的大力支持。临床职责是参加课程的最常见障碍。 参与的 27 家诊所、参与的员工和提供者的范围以及通过调查和定性访谈收集的积极反馈为支持扩大这种治疗方法的 MOUD ECHO 的可行性和可接受性提供了证据。然而,参与的障碍对可行性构成了重要威胁。了解可行性和可接受性是研究 ECHO 扩大 OUD 治疗影响的重要组成部分。